πŸ‡ΊπŸ‡Έ FDA
Patent

US 11873291

Quinoline cGAS antagonist compounds

granted A61PA61P25/28A61P29/00

Quick answer

US patent 11873291 (Quinoline cGAS antagonist compounds) held by The Board of Regents of the University of Texas System expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
52
CPC classes
A61P, A61P25/28, A61P29/00